Nivolumab plus brentuximab vedotin for relapsed/refractory primary mediastinal large b-cell lymphoma: extended follow-up from the phase 2 checkmate 436 study P. L. Zinzani,Armando Santoro,Giuseppe Gritti,Pauline Brice,Paul M. Barr,John Kuruvilla,David Cunningham,Justin Kline,Nathalie A. Johnson,Neha Mehta-Shah,Michelle A. Fanale,Stephen Francis, A.J. MoskowitzHematological Oncology（2021）引用 5|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
